{"id":45435,"date":"2023-11-20T05:13:18","date_gmt":"2023-11-20T11:13:18","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-data\/"},"modified":"2023-11-20T05:13:18","modified_gmt":"2023-11-20T11:13:18","slug":"aren0532-data","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-data\/","title":{"rendered":"AREN0532-DATA"},"template":"","class_list":["post-45435","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Data Citation","tcia_citation_text":"<p><span><span><span><span>Fernandez, C. V., Mullen, E. A., Chi, Y.-Y., Ehrlich, P. F., Perlman, E. J., Kalapurakal, J. A., Khanna, G., Paulino, A. C., Hamilton, T. E., Gow, K. W., Tochner, Z., Hoffer, F. A., Withycombe, J. S., Shamberger, R. C., Kim, Y., Geller, J. I., Anderson, J. R., Grundy, P. E., &amp; Dome, J. S. (2022). Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms\u2019 Tumor (AREN0532) (Version 1) [Data set]. The Cancer Imaging Archive<\/span>. <a href=\"https:\/\/doi.org\/10.7937\/6PJ1-M859\">https:\/\/doi.org\/10.7937\/6PJ1-M859<\/a><\/span><\/span><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.7937\/6PJ1-M859","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/45435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=45435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}